Loading clinical trials...
Loading clinical trials...
Defining Parameters to Optimize Neurostimulation for the Treatment of Pediatric Depression
Repetitive TMS (rTMS) is a well-established method for modulating brain activity. Through successive stimulations in the form of magnetic fields, it is possible to modify the sensitivity of neurons in the brain, also known as cortical excitability. Cortical excitability is important for the induction of brain plasticity, the ability of the brain to reorganize itself and form new connections in response to stimuli. A particular class of rTMS, intermittent theta burst TMS (iTBS), is commonly used to modulate cortical excitability and induce plasticity for therapeutic purposes, notably for treatment-resistant depression. Different iTBS stimulation parameters can be used to induce plasticity. This study will focus on two parameters, namely, the form and duration of the electromagnetic stimulation. The shape of the electromagnetic pulse refers to how the electromagnetic wave is configured over time, while the duration is simply the period during which this electromagnetic pulse remains active. These parameters are expected to influence the effectiveness of iTBS in modulating cortical activity but remain little studied. The main aim of this study will be to compare the effectiveness of different stimulation parameters in the induction of plasticity, which will then make it possible to improve the rTMS protocols used for treatment-resistant depression.
Age
18 - 35 years
Sex
ALL
Healthy Volunteers
Yes
Centre de recherche du Centre hospitalier universitaire de Sherbrook
Sherbrooke, Quebec, Canada
Start Date
August 1, 2024
Primary Completion Date
December 1, 2025
Completion Date
July 1, 2026
Last Updated
February 10, 2025
30
ESTIMATED participants
Monophasic iTBS
DEVICE
Biphasic iTBS
DEVICE
Monophasic-Long iTBS
DEVICE
Lead Sponsor
Université de Sherbrooke
NCT06251479
NCT06213012
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions